Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous Antibiotic Prophylaxis in Total Hip Replacement
NCT07549542Phase 4Enrolling by invitation
- Sponsor
- Rutgers University
- Start
- Oct 2025
- Primary completion
- Oct 2026
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin in surgical site infection (SSI), sponsored by Rutgers University. Started Oct 2025; status: enrolling by invitation.
02
Drugs
cefazolin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT07549542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549542.